We are live on ! Find out more
CCM

Covington Capital Management Portfolio holdings

AUM $2.32B
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
-12.18%
3 Year Est. Return
+32.05%
5 Year Est. Return
+64.04%
10 Year Est. Return
–
AUM
$1.62B
AUM Growth
+$106M
Cap. Flow
+$9.41M
Cap. Flow %
0.58%
Top 10 Hldgs %
25.64%
Holding
836
New
105
Increased
187
Reduced
152
Closed
27

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$6.53M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$3.89M
3
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.21M
4
CELG
Celgene Corp
CELG
+$1.75M
5
DD icon
DuPont de Nemours
DD
+$1.74M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$4.53M
2
GE icon
GE Aerospace
GE
+$2.96M
3
SLB icon
SLB Ltd
SLB
+$2.49M
4
TGT icon
Target
TGT
+$2M
5
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 11.61%
2 Financials 11.59%
3 Healthcare 10.12%
4 Utilities 9.14%
5 Industrials 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
826
DELISTED
Immunogen Inc
IMGN
– –
-206
Closed -$2K
AXAS
827
DELISTED
Abraxas Petroleum Corp
AXAS
– –
-315
Closed -$12K
BGG
828
DELISTED
Briggs & Stratton Corp.
BGG
– –
-165
Closed -$4K
PTLA
829
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-2,000
Closed -$108K
TIME
830
DELISTED
Time Inc.
TIME
$0 ﹤0.01%
13
-2,343
-99% -$35K
CUNB
831
DELISTED
CU Bancorp
CUNB
– –
-1,310
Closed -$51K
PTX
832
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-1,000
Closed -$3K
FTR
833
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
2
– –
ARLZ
834
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$0 ﹤0.01%
21
– –
BCR
835
DELISTED
CR Bard Inc.
BCR
– –
-45
Closed -$14K
FPO
836
DELISTED
First Potomac Realty Trust
FPO
– –
-92
Closed -$1K
30 31 32 33
34

Similar funds

MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return

Covington Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Covington Capital Management held 836 positions worth $1.62B, up 7% from $1.51B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Covington Capital Management's Q4 2017 filing shows 105 new, 187 increased, 152 reduced and 27 closed positions. Its largest new stake was bluebird bio: 154 shares worth $356K. The largest sale was Allergan plc, an estimated $4.53M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Covington Capital Management's largest Q4 2017 buy was bluebird bio: 154 shares worth $356K.
  • Covington Capital Management added most to Vanguard FTSE Developed Markets ETF in Q4 2017, an estimated $6.53M increase.
  • Covington Capital Management's biggest Q4 2017 reduction was Allergan plc, cutting an estimated $4.53M.
  • Covington Capital Management fully exited CoStar Group in Q4 2017, selling an estimated $402K.
  • Covington Capital Management's ten largest holdings make up 26% of its $1.62B portfolio in Q4 2017.
  • Covington Capital Management opened 105 new positions and closed 27 in Q4 2017.
  • Covington Capital Management's portfolio value rose 7% quarter-over-quarter to $1.62B.

Based on Covington Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.